Abstract
MUTATIONS in the genes encoding amyloid-β precursor protein (APP)1 presenilin 1 (PS1)2 and presenilin 2 (PS2)3,4 are known to cause early-onset, autosomal dominant Alzheimer's disease. Studies of plasma and fibroblasts from subjects with these mutations have established that they all alter amyloid β-protein (βAPP) processing, which normally leads to the secretion of amyloid-β protein (relative molecular mass 4,000; Mr 4K; ∼90% Aβ1–40, ∼10% Aβ1–42(43)), so that the extracellular concentration of Aβ42(43) is increased5. This increase in Aβ42(43) is believed to be the critical change that initiates Alzheimer's disease pathogenesis because Aβ42(43) is deposited early and selectively in the senile plaques that are observed in the brains of patients with all forms of the disease. To establish that the presenilin mutations increase the amount of Aβ42(43) in the brain and to test whether presenilin mutations act as true (gain of function) dominants, we have now constructed mice expressing wild-type and mutant presenilin genes. Analysis of these mice showed that overexpression of mutant, but not wild-type, PS1 selectively increases brain Aβ42(43). These results indicate that the presenilin mutations probably cause Alzheimer's disease through a gain of deleterious function that increases the amount of Aβ42(43) in the brain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Goate, A. et al. Nature 349, 704–706 (1991).
Sherrington, R. et al. Nature 375, 754–760 (1995).
Levy-Lahad, E. et al. Science 269, 973–977 (1995).
Rogaev, E. et al. Nature 376, 775–778 (1995).
Suzuki, N. et al. Science 264, 1335–1340 (1994).
Alzheimer's Disease Collaborative Group Nature Genet. 11, 219–222 (1995).
Haltia, M. et al. Ann. Neurol. 36, 362–367 (1994).
Thinakaran, G. et al. Neuron 17, 181–190 (1996).
Iwatsubo, T. et al. Ann. Neurol. 37, 294–299 (1995).
Gravina, S. A. et al. J. Biol. Chem. 270, 7013–7016 (1995).
Games, D. Nature 373, 523–527 (1995).
Hsiao, K. et al. Science (in the press).
Scheuner, D. et al. Nature Med. 2, 864–870 (1996).
Kovacs, D. M. et al. Nature Med. 2, 224–229 (1996).
Levitan, D. & Greewald, I. Nature 377, 351–354 (1996).
L'Hernault, S. W. & Arduengo, P. M. J. Cell Biol. 119, 55–68 (1992).
Xu, H., Greengard, P. & Gandy, S. J. Biol. Chem. 270, 23243–23245 (1995).
Sasahara, M. et al. Cell 64, 217–227 (1991).
Brinster, R. et al. Proc. Natl Acad. Sci. USA 85, 836–840 (1988).
Suzuki, N. et al. Am. J. Path. 145, 452–460 (1994).
Odaka, N. et al. Biochemistry 34, 10272–10278 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duff, K., Eckman, C., Zehr, C. et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713 (1996). https://doi.org/10.1038/383710a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/383710a0
This article is cited by
-
Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice
Molecular Neurodegeneration (2023)
-
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
Signal Transduction and Targeted Therapy (2023)
-
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Science China Life Sciences (2023)
-
Turning the tide on Alzheimer’s disease: modulation of γ-secretase
Cell & Bioscience (2022)
-
Aβ profiles generated by Alzheimer’s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset
Molecular Psychiatry (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.